COMMUNIQUÉS West-GlobeNewswire

-
Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results
21/02/2025 -
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
21/02/2025 -
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
21/02/2025 -
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
21/02/2025 -
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
21/02/2025 -
Les besoins du patient au centre de toutes les priorités : pourquoi l’Europe doit agir pour protéger l’accès aux médicaments ?
21/02/2025 -
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
21/02/2025 -
Nusano Named “Researcher of the Year” at Inaugural Best of BioHive Awards
21/02/2025 -
Philips publishes its Annual Report 2024
21/02/2025 -
Change to the Executive Leadership Team
21/02/2025 -
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
21/02/2025 -
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
21/02/2025 -
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
21/02/2025 -
Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
21/02/2025 -
White Paper: Polish Presidency of the Council of the European Union 2025. Healthcare Policy Recommendations - A Unique Publication from the Institute for Social Policy Development Now Available
21/02/2025 -
Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights
21/02/2025 -
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
20/02/2025 -
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
20/02/2025 -
NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025
20/02/2025
Pages